Indevus Gains Supprelin LA With Purchase Of Valera

Indevus also expects to out-license Valera's early stage pipeline, as well as several of its own products.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet